PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26525741-0	2015	High SLFN11 expression predicts better survival for patients with KRAS exon 2 wild type colorectal cancer after treated with adjuvant oxaliplatin-based treatment.	Oxaliplatin	134-145	KRAS proto-oncogene, GTPase	Homo sapiens	66-70	
26525741-11	2015	CONCLUSIONS: SLFN11 expression predicts good better survival in colorectal cancer patients with KRAS exon 2 wild type who have received oxaliplatin based adjuvant chemotherapy.	Oxaliplatin	136-147	KRAS proto-oncogene, GTPase	Homo sapiens	96-100